Alza Corporation

Other

Alza Coporation

Susan M Marks

George V Guittard

Francisco Jao

David J Kidney

Fernando E Gumucio

Patrick S Wong

David J Enscore

James L Osborne

Randall G Berggren

Wouter E Roorda

Liang C Dong

Joyce C Anthony

Danusia Szumowski

A composition and a dosage form are disclosed comprising oxybutynin alone/or accompanied by another drug indicated for therapy. A method is disclosed for administering oxybutynin alone/or accompanied by a different drug or for administering oxybutynin and a different drug according to a therapeutic program for the management of incontinence alone, and for other therapy.

Method for the management of incontinence

A composition comprising oxybutynin, a dosage form comprising oxybutynin, and a method for administering oxybutynin are disclosed for oxybutynin therapy.

Oxybutynin therapy

A composition comprising oxybutynin, a device comprising oxybutynin, and a method for administering oxybutynin are disclosed for oxybutynin therapy.

Dosage form and method for treating incontinence

Dosage form comprising oxybutynin

The present invention is directed to a material which can be used to deliver a drug, such as an antibiotic, into a diseased tissue pocket, such as a periodontal pocket. The material is preferably a bioerodible oligomer or polymer. The oligomer or polymer containing the drug is heated and is then delivered, preferably by injection, into the tissue pocket at a physiologically compatible elevated temperature. Once the bioerodible material is injected into the pocket, the material cools to the body temperature of the pocket. As it cools, the material hardens and remains in place in the tissue pocket. The hardened material bioerodes in the pocket and releases the drug over a period of several days.

Injectable drug delivery system and method

A method is described for delivering a beneficial agent, such as an antiinflammatory agent, to the site of a painful condition in the oral cavity of a human being that utilizes an oral dosage form having an immediately releasable topical anesthetic and a sustained release beneficial agent. The topical anesthetic is released substantially independently of the beneficial agent to provide immediate pain relief and the application of the beneficial agent is continued over a long period of time.

Oral dosage and method for treating painful conditions of the oral cavity

A composition comprising oxybutynin and a device comprising oxybutynin are disclosed for oxybutynin therapy.

Growing community of inventors

San Jose, CA, United States of America

Susan M Marks